OBI Pharma, Inc. (TPEX: 4174)
76.30
+0.80 (1.06%)
Sep 11, 2024, 10:00 AM CST
OBI Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -2,155 | -1,046 | -1,614 | -1,531 | -1,378 | -1,407 | Upgrade
|
Depreciation & Amortization | 230.44 | 244.86 | 240.92 | 208.75 | 214.53 | 197.06 | Upgrade
|
Other Amortization | 0.58 | 4.1 | 5.69 | 7.52 | 17.31 | 16.84 | Upgrade
|
Loss (Gain) From Sale of Assets | -43.53 | 0.39 | -0.01 | 15.08 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | 5.96 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -28.5 | -879.32 | 1.02 | -0.37 | -54 | 148.36 | Upgrade
|
Loss (Gain) on Equity Investments | 286.43 | 163.58 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 77.13 | 119.2 | 149 | 54.02 | 76.82 | 153.93 | Upgrade
|
Other Operating Activities | -167.7 | -201.73 | -310.03 | -195.51 | -98.03 | -315.15 | Upgrade
|
Change in Accounts Receivable | 2.79 | -4.44 | 1.43 | -2.01 | 0.07 | -0.47 | Upgrade
|
Change in Inventory | -7.75 | -3.96 | -9.74 | -2.2 | -3.16 | 0.91 | Upgrade
|
Change in Accounts Payable | -1.64 | -0.37 | 0.62 | 0.37 | -0.02 | 0.11 | Upgrade
|
Change in Unearned Revenue | 4.42 | 3.13 | 3.16 | - | -77.64 | 77.64 | Upgrade
|
Change in Other Net Operating Assets | -62.3 | -57.89 | -87.84 | -1.57 | 20.75 | 10.53 | Upgrade
|
Operating Cash Flow | -1,865 | -1,653 | -1,620 | -1,064 | -1,609 | -1,117 | Upgrade
|
Capital Expenditures | -133.58 | -101.93 | -254.65 | -241.33 | -182.68 | -69.54 | Upgrade
|
Sale of Property, Plant & Equipment | 144.83 | 0.2 | 0.05 | - | - | - | Upgrade
|
Cash Acquisitions | - | - | - | 472.65 | - | - | Upgrade
|
Divestitures | -30.41 | -564.08 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -6.02 | -6.23 | -45.91 | -3.86 | -2.96 | -4.95 | Upgrade
|
Investment in Securities | 283.45 | -2,110 | 109.29 | -140 | - | - | Upgrade
|
Other Investing Activities | 8.24 | -13.17 | 21.33 | -4.79 | -10.26 | -4.22 | Upgrade
|
Investing Cash Flow | 266.51 | -2,795 | -169.89 | 82.68 | -195.9 | -78.71 | Upgrade
|
Short-Term Debt Issued | - | - | 15.71 | - | 9.47 | - | Upgrade
|
Total Debt Issued | 50.04 | - | 15.71 | - | 9.47 | - | Upgrade
|
Short-Term Debt Repaid | - | -11.4 | - | -9.47 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -51.61 | -59.31 | -58.07 | -54.6 | -37.31 | Upgrade
|
Total Debt Repaid | -63.84 | -63.01 | -59.31 | -67.54 | -54.6 | -37.31 | Upgrade
|
Net Debt Issued (Repaid) | -13.8 | -63.01 | -43.61 | -67.54 | -45.13 | -37.31 | Upgrade
|
Issuance of Common Stock | 3.31 | 17.61 | 3,150 | 16.99 | 22.94 | 2,026 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -93.46 | Upgrade
|
Other Financing Activities | -0 | 652.47 | 903.59 | 214.3 | 305.29 | - | Upgrade
|
Financing Cash Flow | -10.5 | 607.07 | 4,010 | 163.75 | 283.09 | 1,895 | Upgrade
|
Foreign Exchange Rate Adjustments | 5.91 | -0.56 | 8.53 | -8.06 | 0.54 | -1.84 | Upgrade
|
Net Cash Flow | -1,603 | -3,842 | 2,229 | -826.12 | -1,522 | 697.05 | Upgrade
|
Free Cash Flow | -1,998 | -1,755 | -1,874 | -1,306 | -1,792 | -1,187 | Upgrade
|
Free Cash Flow Margin | -3442.65% | -4223.71% | -39786.71% | -6956.13% | -1272.04% | -21245.99% | Upgrade
|
Free Cash Flow Per Share | -8.72 | -7.66 | -8.44 | -6.56 | -9.02 | -6.19 | Upgrade
|
Cash Interest Paid | 11.07 | 3.74 | 3.99 | 3.8 | 4.18 | 3.9 | Upgrade
|
Cash Income Tax Paid | - | -7.28 | -9.56 | -15.15 | 4.39 | 2.48 | Upgrade
|
Levered Free Cash Flow | -1,279 | -1,228 | -1,406 | -1,002 | -770.41 | -665.37 | Upgrade
|
Unlevered Free Cash Flow | -1,272 | -1,223 | -1,403 | -999.39 | -767.8 | -662.93 | Upgrade
|
Change in Net Working Capital | 52.91 | 176.88 | 171.4 | -48.01 | -25.37 | -29.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.